SL2 ADVANCES IN MOLECULAR BIOLOGY AND GENETICS IN GLIOMA RESEARCH AND THERAPY

door Cavenee, Webster K
Gepubliceerd in Neurooncol Adv (2019)

EL1 BUILDING A CAREER IN NEURO-ONCOLOGY RESEARCH

door Cavenee, Webster K
Gepubliceerd in Neurooncol Adv (2019)

Stem Cells for Treating Glioblastoma: How Close to Reality?

door James, C. David, Cavenee, Webster K.
Gepubliceerd in 2009

Regulation of cholesterol biosynthesis in HeLa S3G cells by serum lipoproteins: Dexamethasone-mediated interference with suppression of 3-hydroxy-3-methylglutaryl coenzyme A reduct...

door Cavenee, Webster K., Johnston, Dean, Melnykovych, George
Gepubliceerd in 1978

mTORC2 dictates Warburg effect and drug resistance

door Masui, Kenta, Cavenee, Webster K, Mischel, Paul S
Gepubliceerd in 2014

mTORC2 in the center of cancer metabolic reprogramming

door Masui, Kenta, Cavenee, Webster K., Mischel, Paul S.
Gepubliceerd in 2014

mTORC2 and Metabolic Reprogramming in GBM: at the Interface of Genetics and Environment

door Masui, Kenta, Cavenee, Webster K., Mischel, Paul S.
Gepubliceerd in Brain Pathol (2015)

Cancer metabolism as a central driving force of glioma pathogenesis

door Masui, Kenta, Cavenee, Webster K., Mischel, Paul S.
Gepubliceerd in Brain Tumor Pathol (2016)

Precision cancer therapy is impacted by oncogene-dependent epigenome remodeling

door Liu, Feng, Mischel, Paul S., Cavenee, Webster K.
Gepubliceerd in NPJ Precis Oncol (2017)

Therapeutic targeting of epidermal growth factor receptor in human cancer: successes and limitations

door Wykosky, Jill, Fenton, Tim, Furnari, Frank, Cavenee, Webster K.
Gepubliceerd in 2011

Targeting EGFR for Treatment of Glioblastoma: Molecular Basis to Overcome Resistance

door Taylor, Tiffany E., Furnari, Frank B., Cavenee, Webster K.
Gepubliceerd in 2012

Extracellular nutrients are required to maintain oncogenic signaling in brain cancer – a critical role for mTORC2

door Masui, Kenta, Shibata, Noriyuki, Cavenee, Webster K., Mischel, Paul S.
Gepubliceerd in Bioessays (2016)

PAX3-FOXO1 controls expression of the p57Kip2 cell-cycle regulator through degradation of EGR1

door Roeb, Wendy, Boyer, Antonia, Cavenee, Webster K., Arden, Karen C.
Gepubliceerd in 2007

Heterogeneity Maintenance in Glioblastoma: a social network

door Bonavia, Rudy, Inda, Maria-del-Mar, Cavenee, Webster, Furnari, Frank
Gepubliceerd in 2011

Arsenic reverses glioblastoma resistance to mTOR-targeted therapies

door Iwanami, Akio, Cloughesy, Timothy F., Cavenee, Webster K., Mischel, Paul S.
Gepubliceerd in 2013

ATPS-86 MUTATIONS IN THE EGF RECEPTOR EXTRACELLULAR DOMAIN REVEAL AN UNTETHERED TRANSITIONAL STATE WHICH MEDIATES mAb806 BINDING

door Thorne, Amy Haseley, Orellana, Laura, Parisian, Alison, Cavenee, Webster, Furnari, Frank
Gepubliceerd in Neuro Oncol (2015)

Heterogeneity of epidermal growth factor receptor signalling networks in glioblastoma

door Furnari, Frank B., Cloughesy, Timothy F., Cavenee, Webster K., Mischel, Paul S.
Gepubliceerd in Nat Rev Cancer (2015)

Codependency of Metabolism and Epigenetics Drives Cancer Progression: A Review

door Masui, Kenta, Harachi, Mio, K. Cavenee, Webster, S. Mischel, Paul, Shibata, Noriyuki
Gepubliceerd in Acta Histochem Cytochem (2020)

Protein Acetylation at the Interface of Genetics, Epigenetics and Environment in Cancer

door Harachi, Mio, Masui, Kenta, Cavenee, Webster K., Mischel, Paul S., Shibata, Noriyuki
Gepubliceerd in Metabolites (2021)

Intracerebral tumor-associated hemorrhage caused by overexpression of the vascular endothelial growth factor isoforms VEGF(121) and VEGF(165) but not VEGF(189)

door Cheng, Shi-Yuan, Nagane, Motoo, Huang, H.-J. Su, Cavenee, Webster K.
Gepubliceerd in 1997